Chongqing

Food Processing Standards are Tested as Coronavirus Outbreak Intensifies Globally

Retrieved on: 
Tuesday, February 25, 2020

A major advantage the food processing market has is its use of various methods and technologies to detect infectious diseases.

Key Points: 
  • A major advantage the food processing market has is its use of various methods and technologies to detect infectious diseases.
  • New modern regulations, monitoring, adoption of technologies and integrity of farmers as well as food processing companies should help manage the outbreak, reducing risk of spreading infectious diseases.
  • The new coronavirus (named "2019-nCoV"), which originated in Wuhan, China, is the most recent example of a devastating outbreak.
  • About China Xiangtai Food Co., Ltd.: Headquartered in Chongqing, China, China Xiangtai Food Co., Ltd, is a food company primarily engaged in pork processing.

Food Processing Standards are Tested as Coronavirus Outbreak Intensifies Globally

Retrieved on: 
Tuesday, February 25, 2020

A major advantage the food processing market has is its use of various methods and technologies to detect infectious diseases.

Key Points: 
  • A major advantage the food processing market has is its use of various methods and technologies to detect infectious diseases.
  • New modern regulations, monitoring, adoption of technologies and integrity of farmers as well as food processing companies should help manage the outbreak, reducing risk of spreading infectious diseases.
  • The new coronavirus (named "2019-nCoV"), which originated in Wuhan, China, is the most recent example of a devastating outbreak.
  • About China Xiangtai Food Co., Ltd.: Headquartered in Chongqing, China, China Xiangtai Food Co., Ltd, is a food company primarily engaged in pork processing.

China Xiangtai Food Co., Ltd. Announces Cooperation with Dragon Gate Investment Partners

Retrieved on: 
Tuesday, February 18, 2020

NEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) -- China Xiangtai Food Co., Ltd. (NASDAQ: PLIN) (Xiangtai or the Company), an emerging growth company engaged in food processing business in China, today announced that it has engaged Dragon Gate Investment Partners as its financial advisor.

Key Points: 
  • NEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) -- China Xiangtai Food Co., Ltd. (NASDAQ: PLIN) (Xiangtai or the Company), an emerging growth company engaged in food processing business in China, today announced that it has engaged Dragon Gate Investment Partners as its financial advisor.
  • We are glad to announce our partnership with Dragon Gate Investment Partners, said Mr. Xiaohui Wu, President and Director of China Xiangtai Food Co., Ltd.
    We believe Dragon Gates expertise can help us to build an interactive and stable communication channel, meanwhile establishing cooperation with US partners.
  • We are glad to become the financial advisor of China Xiangtai Food Co., Ltd. said Ms. Lijie Zhu, Managing Director of Dragon Gate Investment Partners.
  • About China Xiangtai Food Co., Ltd
    Headquartered inChongqing, China,China Xiangtai Food Co., Ltd, is a food company primarily engaged in pork processing.

BOQI International Medical Enters into Material Definitive Agreement to Acquire Chongqing Guanzan Technology

Retrieved on: 
Monday, February 3, 2020

Chongqing Guanzan also has about ten world-leading medical device suppliers such as Stryker, GE, Siemens, Philips and Olympus.

Key Points: 
  • Chongqing Guanzan also has about ten world-leading medical device suppliers such as Stryker, GE, Siemens, Philips and Olympus.
  • Pursuant to the Agreement, the Buyer will purchase all the issued and outstanding shares (the Shares) of Chongqing Guanzan.
  • By joining BOQI International Medical, Chongqing Guanzan and our employees will benefit from its supply chain management, as well as the greater resources of a larger, public company, said Xiaoping Wang, Chief Executive Officer of Chongqing Guanzan.
  • About BOQI International Medical Inc.
    BOQI International Medical Inc. (formerly known as NF Energy Saving Corporation) (NASDAQ: BIMI) was founded in 2006.

Investigation Report on Chinese Pregabalin Market During the Period, 2020-2024 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 28, 2020

The "Investigation Report on Chinese Pregabalin Market, 2020-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Investigation Report on Chinese Pregabalin Market, 2020-2024" report has been added to ResearchAndMarkets.com's offering.
  • Chongqing Succeway Pharmaceutical Co., Ltd.'s Pregabalin (trade name: Lairuike) was put in the market after obtaining the production license in 2013 and is gradually taking market share from Pfizer.
  • It is estimated that Pfizer's Lyrica will continue to dominate the Chinese market from 2020 to 2024 but its market share will decline because of the price competition of China-made Pregabalin.
  • 2 Market Overview of Pregabalin in China, 2013-2018
    2.3 Investigation on Market Size of Pregabalin by Dosage Form in China, 2013-2018
    3 Investigation on Market Share of Major Pregabalin Manufacturers in China, 2013-2018
    3.3 Chongqing Succeway Pharmaceutical Co., Ltd.
    4 Sales Price of Pregabalin in China Market, 2019
    4.2.2 Chongqing Succeway Pharmaceutical Co., Ltd.(Lairuike)
    5 Prospect of Pregabalin Market, 2020-2024
    5.3 Forecast on Market Size of Pregabalin in China, 2020-2024
    View source version on businesswire.com: https://www.businesswire.com/news/home/20200128005374/en/

China Pregabalin Market Analysis and Outlook 2013-2024 - Major Manufacturers' Market Shares, Sales Price, Future Prospects

Retrieved on: 
Thursday, January 23, 2020

DUBLIN, Jan. 23, 2020 /PRNewswire/ -- The "Investigation Report on Chinese Pregabalin Market, 2020-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 23, 2020 /PRNewswire/ -- The "Investigation Report on Chinese Pregabalin Market, 2020-2024" report has been added to ResearchAndMarkets.com's offering.
  • Chongqing Succeway Pharmaceutical Co. Ltd.'s Pregabalin (trade name: Lairuike) was put in the market after obtaining the production license in 2013 and is gradually taking market share from Pfizer.
  • By sales value, in 2018, Pfizer's Lyrica had a market share of approximately 77.13%, and the rest market share was captured by the products of Chongqing Succeway Pharmaceutical Co. Ltd.
  • 2 Market Overview of Pregabalin in China, 2013-2018
    2.3 Investigation on Market Size of Pregabalin by Dosage Form in China, 2013-2018
    3 Investigation on Market Share of Major Pregabalin Manufacturers in China, 2013-2018
    3.3 Chongqing Succeway Pharmaceutical Co. Ltd.
    4 Sales Price of Pregabalin in China Market, 2019
    4.2.2 Chongqing Succeway Pharmaceutical Co. Ltd.(Lairuike)
    5 Prospect of Pregabalin Market, 2020-2024
    5.3 Forecast on Market Size of Pregabalin in China, 2020-2024
    Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Xinhua Silk Road: Xinhua-Fengjie Navel Orange Price Index released in SW China's Chongqing

Retrieved on: 
Monday, December 16, 2019

CHONGQING, China, Dec. 16, 2019 /PRNewswire/-- The Xinhua-Fengjie Navel Orange Price Index was released on Sunday in Fengjie County, southwest China's Chongqing municipality.

Key Points: 
  • CHONGQING, China, Dec. 16, 2019 /PRNewswire/-- The Xinhua-Fengjie Navel Orange Price Index was released on Sunday in Fengjie County, southwest China's Chongqing municipality.
  • The Xinhua-Fengjie Navel Orange Price Index has recently shown a downtrend.
  • "The navel orange price index will help achieve standardization and digitization of the navel orange production, packaging, and transportation industry chain," said Cai Ping, deputy director of the Information Center of the Ministry of Agriculture and Rural Affairs.
  • It is learned that in recent years, Fengjie County has taken measures to enhance quality of the navel orange industry.

NF Energy Saving Corporation Enters into MOU to Acquire Chongqing Guanzan Technology

Retrieved on: 
Monday, December 2, 2019

BIMI intends that Chongqing Guanzan will operate as a wholly-owned subsidiary led by its existing management team.

Key Points: 
  • BIMI intends that Chongqing Guanzan will operate as a wholly-owned subsidiary led by its existing management team.
  • If the contemplated acquisition fails due to reasons attributable to Chongqing Guanzan, Chongqing Guanzan shall pay a breakup fee in the amount of $150,000 to BIMI.
  • NF Energy Saving Corporation (NASDAQ: BIMI) is a China-based provider of integrated energy conservation solutions utilizing energy-saving equipment, technical services and energy management re-engineering project operations to provide energy saving services to clients.
  • About Chongqing Guanzan Technology Co., Ltd.
    Chongqing Guanzan Technology Co., Ltd. is a Chinese wholesaler and retailer of medical devices.

Chongqing Liangjiang New Area attracts global talents

Retrieved on: 
Tuesday, November 5, 2019

CHONGQING, China, Nov. 5, 2019 /PRNewswire/ -- The Chongqing Talents Conference will be held in the municipality's Liangjiang New Area on November 9, with a focus on gathering talents from home and abroad to support the high-quality development.

Key Points: 
  • CHONGQING, China, Nov. 5, 2019 /PRNewswire/ -- The Chongqing Talents Conference will be held in the municipality's Liangjiang New Area on November 9, with a focus on gathering talents from home and abroad to support the high-quality development.
  • Liangjiang New Area, the host of the conference, is the country's third state-level new area and the first one in inland China.
  • Liangjiang New Area is the core area of the Chongqing pilot free trade zone and China-Singapore connectivity project.
  • As a national new area, Liangjiang New Area boasts preferable institutional advantages, with streamlined institutions, flexible mechanisms and efficient administration services.

NF Energy Saving Corporation Signs Strategic Partnership Agreements With Chengdu Gaoxin Hospital and Chongqing Guoyitang Hospital

Retrieved on: 
Friday, November 1, 2019

New York, Nov. 01, 2019 (GLOBE NEWSWIRE) -- NF Energy Saving Corporation (NASDAQ: BIMI) (BIMI or the "Company") announced today that it entered into strategic partnership agreements with Chengdu Gaoxin Hospital of Tradition Chinese Medicine Co., Ltd. (Chengdu Gaoxin Hospital) and Chongqing Guoyitang Hospital Co., Ltd. (Chongqing Guoyitang Hospital) through its wholly-owned subsidiary Boqi Zhengji Pharmacy Chain Co., Ltd. (Boqi Zhengji Pharmacy), to drive member engagement and provide better healthcare service for members.

Key Points: 
  • New York, Nov. 01, 2019 (GLOBE NEWSWIRE) -- NF Energy Saving Corporation (NASDAQ: BIMI) (BIMI or the "Company") announced today that it entered into strategic partnership agreements with Chengdu Gaoxin Hospital of Tradition Chinese Medicine Co., Ltd. (Chengdu Gaoxin Hospital) and Chongqing Guoyitang Hospital Co., Ltd. (Chongqing Guoyitang Hospital) through its wholly-owned subsidiary Boqi Zhengji Pharmacy Chain Co., Ltd. (Boqi Zhengji Pharmacy), to drive member engagement and provide better healthcare service for members.
  • Founded in 2015, Chongqing Guoyitang Hospital is a full-service hospital located in Southwest China with more than 200 employees.
  • We are excited to be part of this strategic partnership with Boqi Zhengji Pharmacy, said Xiuying Qin, President of Chengdu Gaoxin Hospital.
  • The strategic partnership creates a new avenue for us to meet the evolving needs of healthcare consumers through Chengdu Gaoxin Hospital and Chongqing Guoyitang Hospitals specialized medical treatment and diagnosis, said Mr. Tiewei Song, Chief Executive Officer and President of NF Energy Saving Corporation.